Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling
Certara Model Designer brings cloud based pharmacometric modeling to your browser, with a curated model…
Arjen BosJuly 16, 2026
Enhanced Bioavailability of a Novel Oil-Based Lutein Formulation: A Randomized, Double-Blind, Single-Dose, Comparative Oral Bioavailability Study in Healthy Adults
See how a randomized, double-blind study proved enhanced bioavailability of a novel oil-based lutein formulation,…
CertaraJuly 14, 2026
Pharmacokinetics of Fentanyl and Norfentanyl in a Rat Model of Fixed-Volume Hemorrhagic Shock
Learn how a fixed-volume rat shock model shows increased fentanyl exposure and impaired clearance, analyzed…
CertaraJuly 4, 2026
5 Key Principles of Modern PK/PD in 2026
Explore other Phoenix solutions to enhance your PK/PD workflow and discover how Phoenix helps you…
CertaraJune 30, 2026
63 runs and no convergence: When RsNLME succeeded where other PK/PD solutions couldn’t
After 63 failed runs on a 16-ODE neutropenia model, RsNLME achieved PK/PD convergence on the…
Stephen DuffullJune 23, 2026
External validation of the population pharmacokinetic model of meropenem in patients undergoing neonatal extracorporeal membrane oxygenation and continuous renal replacement therapy
Find out how external validation shows meropenem PopPK model is best used with Bayesian TDM…
CertaraJune 23, 2026
Model Smarter, Not Harder: Introducing Model Designer
Watch Model Designer on demand: Certara's browser based tool for faster NLME model discovery, configuration,…
CertaraJune 10, 2026
Comparative Pharmacokinetics of Two Extended-Release Tablet Formulations of Upadacitinib: Bioequivalence Assessment
Explore how ER upadacitinib formulations met 80–125% bioequivalence criteria under fasting and fed conditions using…
CertaraJune 1, 2026
Effect of High-Fat Meal on the Pharmacokinetics and Safety of Lansoprazole Enteric-Coated Capsules in Healthy Chinese Subjects
Discover how high-fat meal reduces lansoprazole exposure by up to 61% in a bioequivalence study…
CertaraJune 1, 2026
